Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$205.19 - $232.99 $760,434 - $863,460
3,706 Added 56.88%
10,221 $2.26 Million
Q1 2023

May 11, 2023

SELL
$212.99 - $276.17 $25.1 Million - $32.6 Million
-117,992 Reduced 94.77%
6,515 $1.46 Million
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $19.6 Million - $26.7 Million
95,310 Added 326.44%
124,507 $34.6 Million
Q3 2022

Nov 10, 2022

SELL
$203.3 - $244.17 $5.97 Million - $7.17 Million
-29,362 Reduced 50.14%
29,197 $6.11 Million
Q2 2022

Aug 19, 2022

BUY
$174.81 - $241.14 $5.74 Million - $7.92 Million
32,860 Added 127.86%
58,559 $13.8 Million
Q1 2022

May 13, 2022

BUY
$166.16 - $213.96 $4.01 Million - $5.16 Million
24,108 Added 1515.27%
25,699 $4.61 Million
Q4 2021

Feb 11, 2022

SELL
$184.32 - $216.08 $1.93 Million - $2.26 Million
-10,474 Reduced 86.81%
1,591 $344,000
Q3 2021

Nov 15, 2021

SELL
$179.86 - $214.88 $2.7 Million - $3.22 Million
-14,991 Reduced 55.41%
12,065 $2.23 Million
Q2 2021

Aug 16, 2021

BUY
$170.47 - $211.93 $677,447 - $842,209
3,974 Added 17.22%
27,056 $4.85 Million
Q1 2021

May 17, 2021

SELL
$153.94 - $174.85 $2.17 Million - $2.47 Million
-14,106 Reduced 37.93%
23,082 $3.86 Million
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $3.47 Million - $5.16 Million
34,020 Added 1073.86%
37,188 $5.65 Million
Q3 2020

Nov 16, 2020

BUY
$99.9 - $121.13 $316,483 - $383,739
3,168 New
3,168 $320,000
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $1.11 Million - $1.51 Million
-12,017 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $624,640 - $907,573
7,868 Added 189.64%
12,017 $1.14 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $3.02 Million - $3.67 Million
-38,504 Reduced 90.27%
4,149 $365,000
Q3 2019

Nov 14, 2019

BUY
$74.85 - $85.99 $2.71 Million - $3.11 Million
36,171 Added 558.02%
42,653 $3.4 Million
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $493,020 - $783,090
6,482 New
6,482 $506,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.9B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.